AI-generated summary
The authors present a narrative review of preclinical and clinical studies on photobiomodulation (low-level laser therapy) for nervous system disorders, drawing on literature found through database searches. They describe proposed biological mechanisms involving mitochondrial cytochrome c oxidase and conclude that PBM shows potential as a non-invasive option, while stating that further research is needed to optimize protocols and clarify long-term efficacy and safety.
- Who or what was studied
- Patients with central and peripheral nervous system disorders, as well as preclinical models; the abstract does not specify a count.
- Limits stated in the abstract
- The abstract describes a narrative review without a systematic method, does not report the number of included studies, and states that long-term efficacy and safety remain unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Reactive oxygen species, Cytochrome c oxidase, Laser, Adenosine triphosphate. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.